Gabelli Funds’s Urovant Sciences Ltd. UROV Stock Holding History

Gabelli Funds’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-241,227	Closed	-$3.89M	–	1440
2020 Q4	$3.89M	Buy	+241,227	New	+$2.99M	0.03%	538

Gabelli Funds's UROV Position: Q1 2021 in Review

Gabelli Funds sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 241,227 shares — an estimated $3.89M sold.

Gabelli Funds first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $3.89M in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Gabelli Funds reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Gabelli Funds sold 241,227 Urovant Sciences Ltd. shares in Q1 2021, an estimated $3.89M.
Gabelli Funds first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
Gabelli Funds's Urovant Sciences Ltd. position peaked at $3.89M in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Gabelli Funds's 13F filing for Q1 2021, filed 14 May 2021.